EP Patent

EP3581199A1 — Method of treating or reducing efp

Assigned to Endo Global Ventures · Expires 2019-12-18 · 6y expired

What this patent protects

The present invention is directed to a method of treating or reducing EFP in a patient comprising administering one or multiple low dose injections of collagenase to an area affected by EFP. The invention encompasses methods wherein the dose of collagenase per injection is betwee…

USPTO Abstract

The present invention is directed to a method of treating or reducing EFP in a patient comprising administering one or multiple low dose injections of collagenase to an area affected by EFP. The invention encompasses methods wherein the dose of collagenase per injection is between about 50 to about 200 ABC units and/or wherein the concentration of collagenase is between about 50 to about 2000 ABC units/milliliter (ml).

Drugs covered by this patent

Patent Metadata

Patent number
EP3581199A1
Jurisdiction
EP
Classification
—
Expires
2019-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Endo Global Ventures
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.